Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,312 | -22,492 | -120,459 | -80,789 | -49,999 |
| Depreciation Amortization | 764 | 344 | -2,305 | -2,303 | -1,758 |
| Accounts payable and accrued liabilities | 2,035 | 957 | 2,067 | 191 | 1,795 |
| Other Working Capital | 310,604 | 332,964 | 100,694 | 82,222 | 88,353 |
| Other Operating Activity | 20,333 | 9,311 | 19,311 | 14,911 | 7,841 |
| Operating Cash Flow | $279,424 | $321,084 | $-692 | $14,232 | $46,232 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,358 | -1,380 | -6,349 | -5,314 | -3,856 |
| Purchase Of Investment | -529,041 | -349,155 | -362,120 | -319,919 | -222,286 |
| Sale Of Investment | 254,000 | 84,000 | 418,000 | 306,000 | 228,000 |
| Other Investing Activity | 15 | 15 | 0 | 0 | 0 |
| Investing Cash Flow | $-278,384 | $-266,520 | $49,531 | $-19,233 | $1,858 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 45,742 | 39,780 | 52,938 | 842 | 842 |
| Common Stock Repurchased | -104 | N/A | N/A | -50 | -50 |
| Other Financing Activity | -24 | -12 | -50 | 0 | 0 |
| Financing Cash Flow | $45,614 | $39,768 | $52,888 | $792 | $792 |
| Exchange Rate Effect | N/A | N/A | N/A | -4 | N/A |
| Beginning Cash Position | 156,710 | 156,710 | 54,983 | 54,983 | 54,983 |
| End Cash Position | 203,364 | 251,042 | 156,710 | 50,770 | 103,865 |
| Net Cash Flow | $46,654 | $94,332 | $101,727 | $-4,213 | $48,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | 279,424 | 321,084 | -692 | 14,232 | 46,232 |
| Capital Expenditure | -3,358 | -1,380 | -6,349 | -5,314 | -3,856 |
| Free Cash Flow | 276,066 | 319,704 | -7,041 | 8,918 | 42,376 |